Intellectual Property India Publishes Patent Application for 'A Ready-To-Use, Stable Formulation Of Lacosamide Injection And Method Thereof' Filed by Maiva Pharma Private Limited

MUMBAI, India, Feb. 6 -- Intellectual Property India has published a patent application (202541084655 A) filed by Maiva Pharma Private Limited, Hosur, Tamil Nadu, on Sept. 5, 2025, for 'a ready-to-use, stable formulation of lacosamide injection and method thereof.'

Inventor(s) include Alagumurugan Alagarswamy; and Derfla Alfred.

The application for the patent was published on Feb. 6, under issue no. 06/2026.

According to the abstract released by the Intellectual Property India: "According to an embodiment of the present disclosure, a ready-to-use room temperature stable, isotonic, Lacosamide injection suitable for intravenous infusion administration without the need for any further dilution prior to administration, comprising a lacosamid...